Literature DB >> 8335208

Liver transplantation for acute liver failure: analysis of applicability.

A Castells1, J M Salmerón, M Navasa, A Rimola, J Saló, H Andreu, A Mas, J Rodés.   

Abstract

BACKGROUND: Liver transplantation has emerged as the most important advance in the therapy of acute liver failure. To assess the applicability of liver transplantation in this setting, the outcome of 62 patients with acute liver failure consecutively admitted to hospital was analyzed.
METHODS: Criteria for indicating liver transplantation were grade III-IV hepatic encephalopathy or progression of encephalopathy following a transient improvement. In subfulminant cases, liver transplantation was also indicated when no improvement was observed after a 3-day period of conservative treatment.
RESULTS: Thirteen (21%) of the 62 patients never met criteria for transplant indication; all of them were discharged after receiving conventional therapy. Twenty-one (34%) patients with criteria for indicating liver transplantation could not receive the transplant because of either contraindications (17 patients; only 1 being discharged from hospital) or death before donor organ availability (4 patients). Finally, 28 (45%) patients received a liver transplant and 22 were discharged from hospital.
CONCLUSIONS: The applicability of liver transplantation in acute liver failure is relatively low. Considering the high survival rate (79%) obtained in the patients with transplantations and the poor survival rate (6%) observed in those who could not be transplanted, efforts should be made to increase liver transplant applicability to improve the prognosis in acute liver failure.

Entities:  

Mesh:

Year:  1993        PMID: 8335208     DOI: 10.1016/0016-5085(93)90731-q

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  Who needs a liver transplant? (new disease specific indications).

Authors:  A Baker; A Dhawan; N Heaton
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

2.  Hepatitis G virus infection in fulminant hepatic failure.

Authors:  J C Sáiz; M Sans; A Mas; E Olmedo; X Forns; F X López-Labrador; J C Restrepo; J Costa; J M Salmerón; M Guilera; S Ampurdanés; J M Sánchez-Tapias; M T Jiménez de Anta; J Rodés
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

3.  Hyperlactatemia in patients with non-acetaminophen-related acute liver failure.

Authors:  Pilar Taurá; Graciela Martinez-Palli; Julia Martinez-Ocon; Joan Beltran; Gerard Sanchez-Etayo; Jaume Balust; Teresa Anglada; Antoni Mas; Juan-Carlos Garcia-Valdecasas
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

Review 4.  Etiology and management of fulminant hepatic failure.

Authors:  Javier Vaquero; Andres T Blei
Journal:  Curr Gastroenterol Rep       Date:  2003-02

5.  Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience.

Authors:  H Bismuth; D Samuel; D Castaing; R Adam; F Saliba; M Johann; D Azoulay; B Ducot; L Chiche
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

6.  A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India.

Authors:  Prasenjit Das; Deepali Jain; Ashim Das
Journal:  Diagn Pathol       Date:  2007-07-27       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.